Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · MTF

Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer

FDA classification: Unknown. Device class 3.

Product / regulatory recordCompanyPathwayDecision dateSource
Siemens Healthcare Diagnostics, Inc.PMA supplementSep 22, 2026FDA
Siemens Healthcare Diagnostics, Inc.PMA supplementAug 26, 2026FDA
Siemens Healthcare Diagnostics, Inc.PMA supplementAug 20, 2026FDA
IMMULITE 2000 PSAP930027/S039
Siemens Healthcare Diagnostics, Inc.PMA supplementJul 27, 2026FDA
Roche Diagnostics Corp.PMA supplementApr 29, 2026FDA
IMMULITE 2000 PSAP930027/S038
Siemens Healthcare Diagnostics, Inc.PMA supplementApr 21, 2026FDA
Roche Diagnostics Corp.PMA supplementFeb 27, 2026FDA
ABBOTT LABORATORIESPMA supplementFeb 23, 2026FDA
ABBOTT LABORATORIESPMA supplementFeb 12, 2026FDA
Siemens Healthcare Diagnostics, Inc.PMA approvalDec 3, 2025FDA
IMMULITE 2000 PSAP930027/S037
Siemens Healthcare Diagnostics, Inc.PMA supplementOct 30, 2025FDA
Siemens Healthcare Diagnostics, Inc.PMA supplementAug 14, 2025FDA
Siemens Healthcare Diagnostics, Inc.PMA approvalSep 15, 1995FDA
Source information

Follow the FDA links to view the original records.

All device categories